Status:
UNKNOWN
Creatine Supplementation in Pediatric Rheumatology
Lead Sponsor:
University of Sao Paulo
Conditions:
Juvenile Systemic Lupus Erythematosus
Juvenile Dermatomyositis
Eligibility:
All Genders
6-18 years
Phase:
NA
Brief Summary
Creatine supplementation may improve strength, muscle mass, bone mass and muscle function in healthy and elderly people. The investigators speculate that creatine supplementation could have therapeuti...
Eligibility Criteria
Inclusion
- patients diagnosed with lupus systemic erythematosus and juvenile dermatomyositis
- physically inactive
- stable pharmacological treatment
Exclusion
- macroalbuminuria
- GFR \< 30 mL/min/1.73m2
- use of oral anticontraceptive agents
- pregnancy
- diabetes mellitus
- hypothyroidism
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2012
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01217320
Start Date
January 1 2011
End Date
September 1 2012
Last Update
January 16 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Sao Paulo
São Paulo, São Paulo, Brazil, 05508-30